163706-51-2 Usage
Description
(2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol is a complex organic compound with a unique molecular structure. It features a tetrahydrofuran ring with specific stereochemistry at the 2nd, 3rd, 4th, and 5th positions. The molecule also contains a 6-amino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl group attached to the 2nd position, which is a key structural element. (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol is characterized by its potential biological activity and is involved in the synthesis of various pharmaceutical agents.
Uses
Used in Pharmaceutical Synthesis:
(2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol is used as a reactant in the synthesis of Cangrelor (C175230), a drug that inhibits platelet aggregation and is used to treat patients undergoing percutaneous coronary intervention. Its unique structure allows it to act as a highly active antiplatelet agent with dual specificity for platelet P2Y1 and P2Y12 ADP receptors.
Used in the Synthesis of Antiplatelet Agents:
(2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol is also used in the synthesis of a host of compounds that act as highly active antiplatelet agents. Its presence in these agents contributes to their ability to modulate platelet function, which is crucial in the prevention and treatment of thrombotic disorders.
Used in Research and Development:
In addition to its applications in pharmaceutical synthesis, (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol is utilized in research and development for the discovery of new therapeutic agents. Its unique properties and reactivity make it a valuable tool in the design and synthesis of novel compounds with potential medicinal applications.
Used in Drug Delivery Systems:
As with other complex organic compounds, (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol may also be employed in the development of drug delivery systems. These systems aim to improve the bioavailability, targeting, and therapeutic efficacy of the compounds in which it is involved, enhancing their overall performance in treating various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 163706-51-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,7,0 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 163706-51:
(8*1)+(7*6)+(6*3)+(5*7)+(4*0)+(3*6)+(2*5)+(1*1)=132
132 % 10 = 2
So 163706-51-2 is a valid CAS Registry Number.
